Differentiated thyroid cancer (DTC) shows a similar prognosis among both immunocompetent and immunocompromised individuals, according to study findings published in The Journal of Clinical Endocrinology & Metabolism.
DTC is highly curable, with…
Differentiated thyroid cancer outcomes comparable in immunocompromised patients
